Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.
Authors: Jagadeeshan S; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Suryamohan K; BostonGene Corporation, Waltham, MA, USA., Shin N; BostonGene Corporation, Waltham, MA, USA., Mathukkada S; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Boyko A; BostonGene Corporation, Waltham, MA, USA., Melikhova D; BostonGene Corporation, Waltham, MA, USA., Tsareva A; BostonGene Corporation, Waltham, MA, USA., Yunusova L; BostonGene Corporation, Waltham, MA, USA., Pravdivtseva E; BostonGene Corporation, Waltham, MA, USA., Stupichev D; BostonGene Corporation, Waltham, MA, USA., Shaposhnikov K; BostonGene Corporation, Waltham, MA, USA., Peterson A; BostonGene Corporation, Waltham, MA, USA., Bednyagin L; BostonGene Corporation, Waltham, MA, USA., Shugaev-Mendosa E; BostonGene Corporation, Waltham, MA, USA., Kessler L; Kura Oncology, Inc., San Diego, CA, USA., Burrows F; Kura Oncology, Inc., San Diego, CA, USA., Ho AL; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York City, NY, USA., Agrawal N; Department of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, IL, USA., Pearson AT; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA., Izumchenko E; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA., Cole G; Department of Pathology, University of Chicago, Chicago, IL, USA., Elkabets M; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Electronic address: moshee@bgu.ac.il., Rosenberg AJ; Department of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA. Electronic address: arirosenberg@bsd.uchicago.edu.
Source: Oral oncology [Oral Oncol] 2024 Feb; Vol. 149, pp. 106688. Date of Electronic Publication: 2024 Jan 13.
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2024.106688